Sorafenib induces autophagy in human myeloid dendritic cells and prolongs survival of skin allografts

Medicine and Dentistry

• Autophagy 100%
• Sorafenib 100%
• Myeloid Dendritic Cell 100%
• Skin Allograft 100%
• Dendritic Cell 40%
• Mechanistic Target of Rapamycin 20%
• Graft Rejection 20%
• Enzyme Linked Immunosorbent Assay 10%
• Hepatocellular Carcinoma 10%
• Morphology 10%
• Cell Surface 10%
• Signaling Molecule 10%
• down Regulation 10%
• Western Blot 10%
• Anticarcinogen 10%
• Cell Viability 10%
• Clear Cell Renal Cell Carcinoma 10%
• Genetic Transfection 10%
• Immunofluorescence 10%
• Autophagosome 10%
• Vacuolization 10%
• Chloroquine 10%
• 7-Aminoactinomycin D 10%
• Experimental Transplantation 10%
• Transmission Electron Microscopy 10%
• Immunosuppressive Drug 10%
• Antigen 10%
• Skin Graft 10%
• Microscopy 10%

Immunology and Microbiology

• Myeloid Dendritic Cell 100%
• Autophagy 100%
• Sorafenib 100%
• Allograft 100%
• Dendritic Cell 40%
• Sirolimus 20%
• Cell Surface 10%
• Staining 10%
• Western Blot 10%
• down Regulation 10%
• Antigen 10%
• Genetic Transfection 10%
• Cell Viability 10%
• Enzyme-Linked Immunosorbent Assay 10%
• Morphology 10%
• Immunosuppressive Drug 10%
• Transmission Electron Microscopy 10%
• Transplant Rejection 10%
• Autophagosome 10%
• Light Microscopy 10%
• Immunofluorescence 10%
• Dactinomycin 10%
• Chloroquine 10%
• Experimental Transplantation 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Sorafenib 100%
• Graft Rejection 20%
• Mammalian Target of Rapamycin 20%
• Anticarcinogen 10%
• Enzyme-Linked Immunosorbent Assay 10%
• Liver Cell Carcinoma 10%
• Western Blot 10%
• Cell Viability 10%
• Dactinomycin 10%
• Renal Cell Carcinoma 10%
• Transmission Electron Microscopy 10%
• Membrane Antigen 10%
• Immunosuppressive Agent 10%
• Chloroquine 10%